Testing effectiveness (Phase 2)Looking for participantsNCT06868238
What this trial is testing
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
Who this might be right for
Ductal Carcinoma in Situ
University of Florida 30